Your session is about to expire
What is Bevespi Aerosphere
GlycopyrroniumThe Generic name of this drug
Treatment SummaryFormoterol is an inhalable medication used to treat COPD and asthma that was approved for use in the United States in 2001. It helps to open airways in the lungs, allowing for easier breathing. Formoterol is especially useful because it takes effect quickly (2-3 minutes) and lasts for 12 hours. It is available as a single-entity product or in combination with other medications such as inhaled corticosteroids and long-acting muscarinic antagonists.
Robinulis the brand name
Bevespi Aerosphere Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Robinul
Glycopyrronium
1961
294
Effectiveness
How Bevespi Aerosphere Affects PatientsFormoterol is a medication that helps open up the airways in the lungs, allowing for easier breathing. It begins to work within two to three minutes and can last up to twelve hours. It should never be taken without an inhaled corticosteroid as it is linked to an increased risk of asthma-related death.
How Bevespi Aerosphere works in the bodyFormoterol is a medication that targets beta-2 receptors, which are found mostly in the lungs. This helps it to relax the airways and reduce inflammation, making it useful in treating conditions like asthma and COPD. On a molecular level, formoterol activates an enzyme that helps to convert energy into a form that relaxes the lungs and reduces inflammation.
When to interrupt dosage
The suggested measure of Bevespi Aerosphere is contingent upon the diagnosed issue, including Bronchial Asthma, Bronchoconstriction and Asthma. The quantity of dosage fluctuates depending on the administration system (e.g. Solution - Respiratory (inhalation) or Aerosol) noted in the table below.Condition
Dosage
Administration
Anticholinergic Syndrome
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Drooling
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
peripheral muscarinic effects
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Induction of anesthesia therapy
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Peptic Ulcer
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Bodily secretions
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Emphysema
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Choking
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Neurological Conditions
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Hyperhidrosis disorder
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Bronchitis, Chronic
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Oral cavity
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Reflex, Trigeminocardiac
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
cardiac vagal inhibitory reflexes
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Chronic Obstructive Pulmonary Disease
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Increased upper airway secretion
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
General Surgery
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Cerebral Palsy
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Reflex, Trigeminocardiac
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Warnings
Bevespi Aerosphere ContraindicationsCondition
Risk Level
Notes
Ulcerative Colitis
Do Not Combine
Uterine Inertia
Do Not Combine
Ulcerative Colitis
Do Not Combine
Myasthenia Gravis
Do Not Combine
Arterial Occlusive Diseases
Do Not Combine
Cardiovascular Physiological Phenomena
Do Not Combine
Pulse Frequency
Do Not Combine
Therapeutic procedure
Do Not Combine
Paralytic Ileus
Do Not Combine
Open-angle glaucoma
Do Not Combine
Uropathy Obstructive
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Glycopyrronium may interact with Pulse Frequency
Common Bevespi Aerosphere Drug Interactions
Drug Name
Risk Level
Description
Aclidinium
Major
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Aclidinium.
Cimetropium
Major
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Cimetropium.
Eluxadoline
Major
The risk or severity of constipation can be increased when Glycopyrronium is combined with Eluxadoline.
Macimorelin
Major
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycopyrronium.
Secretin human
Major
The therapeutic efficacy of Secretin human can be decreased when used in combination with Glycopyrronium.
Bevespi Aerosphere Toxicity & Overdose RiskThe lowest toxic dose of formoterol in rats is 3130mg/kg. Symptoms of overdose may include chest pain, high or low blood pressure, rapid heartbeat, anxiety, headache, trembling, seizures, and dry mouth. Laboratory tests may also show low levels of potassium, high blood sugar, and acidosis in the blood. Treatment for overdosing on formoterol should involve supportive care, with a focus on monitoring the heart. If necessary, a medication that blocks increased adrenaline may be used.
Bevespi Aerosphere Novel Uses: Which Conditions Have a Clinical Trial Featuring Bevespi Aerosphere?
251 active clinical trials are currently being conducted to evaluate the potential of Bevespi Aerosphere to alleviate symptoms of Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe COPD and Chronic Obstructive Airway Disease.Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
84 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Hyperhidrosis disorder
0 Actively Recruiting
Choking
4 Actively Recruiting
Not Applicable
General Surgery
2 Actively Recruiting
Not Applicable
Increased upper airway secretion
0 Actively Recruiting
Anticholinergic Syndrome
0 Actively Recruiting
Induction of anesthesia therapy
0 Actively Recruiting
Reflex, Trigeminocardiac
0 Actively Recruiting
Emphysema
4 Actively Recruiting
Phase 2
Oral cavity
0 Actively Recruiting
peripheral muscarinic effects
0 Actively Recruiting
Drooling
0 Actively Recruiting
Reflex, Trigeminocardiac
0 Actively Recruiting
Neurological Conditions
0 Actively Recruiting
Bronchitis, Chronic
0 Actively Recruiting
cardiac vagal inhibitory reflexes
0 Actively Recruiting
Peptic Ulcer
0 Actively Recruiting
Bodily secretions
0 Actively Recruiting
Cerebral Palsy
0 Actively Recruiting
Bevespi Aerosphere Reviews: What are patients saying about Bevespi Aerosphere?
5Patient Review
9/13/2019 I was amazed at how quickly this treatment worked. My legs started growing back within two weeks!
4Patient Review
8/29/2018 On the first day, I could breathe again! However, the second day brought on a congestive cough. Reducing the dosage helped it work better for me. This treatment really relaxes my breathing, but I've only been using it for a week so time will tell.
2Patient Review
8/6/2018 I used Bevespi for a couple months, and while it was great at first, my health slowly started declining. I eventually realized that it was the Bevespi causing these issues, specifically the weakness and lack of energy. Formoterol is terrible, and I'll never touch anything with it again.
Patient Q&A Section about bevespi aerosphere
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is BEVESPI AEROSPHERE a steroid?
"Bevespi Aerosphere is not used for asthma because it doesn't contain a steroid medication."
Answered by AI
What type of inhaler is Aerosphere?
"The Bevespi Aerosphere is a handheld canister that gives you a puff of your medicine as an inhaled mist. It is used in the treatment of chronic obstructive pulmonary disease (COPD)."
Answered by AI
What is Bevespi inhaler used for?
"BevESPI Atmosphere is a prescription medication used to manage chronic obstructive pulmonary disease (COPD). COPD encompasses chronic bronchitis, emphysema, or both. BevESPI Atmosphere is to be used as 2 inhalations, 2 times per day--once in the morning and once at night--so as to ease COPD symptoms and promote better breathing."
Answered by AI
What inhaler is comparable to Bevespi?
"Anoro ellipta and Bevespi Aerosphere are combinations of anticholinergics and long acting beta-adrenoceptor agonists (LABAs) used for the long-term, once-daily, maintenance treatment of airflow obstruction in ..."
Answered by AI